KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $95.9 million.

  • Dynavax Technologies' Cash & Equivalents rose 34.29% to $160.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.2 million, marking a year-over-year increase of 34.29%. This contributed to the annual value of $95.9 million for FY2024, which is 36.20% down from last year.
  • Latest data reveals that Dynavax Technologies reported Cash & Equivalents of $95.9 million as of FY2024, which was down 36.20% from $150.3 million recorded in FY2023.
  • Dynavax Technologies' 5-year Cash & Equivalents high stood at $436.2 million for FY2021, and its period low was $32.1 million during FY2020.
  • Over the past 3 years, Dynavax Technologies' median Cash & Equivalents value was $150.3 million (recorded in 2023), while the average stood at $149.4 million.
  • In the last 5 years, Dynavax Technologies' Cash & Equivalents skyrocketed by 1,259.99% in 2021 and then slumped by 53.69% in 2022.
  • Dynavax Technologies' Cash & Equivalents (Yearly) stood at $32.1 million in 2020, then surged by 1,259.99% to $436.2 million in 2021, then slumped by 53.69% to $202.0 million in 2022, then declined by 25.61% to $150.3 million in 2023, then plummeted by 36.20% to $95.9 million in 2024.